InvestorsHub Logo
icon url

Jimmy Quick

10/08/07 2:49 PM

#262 RE: xxplatinum #261

Now that is a legitimate post. Keep your posts more in that line, and they will remain on the board and shareholders can discuss. I am at work, so I don't have time to discuss right now.
icon url

faith works

10/08/07 4:36 PM

#263 RE: xxplatinum #261

XXplatinum, you have several hundred thousand shares at zero cost. Wow. How can you complain when you have no skin in the game?

I am not concerned about no US sales. I've worked for foreign companies who have exceled in their international markets but failed in the US. And yet they were cash flow positive with no debt, the case of eFotoXpress, and were successful in their niches.

I have 20 years of high level management in high tech. Finding your niche and exploiting it is the ticket to success for any start-up. eFotoXpress has finally done that... witness the sales Edward Tan is making with much greater ease than with previous products. We don't need another Microsoft or Google. No one is expecting that from eFotoXpress. You just need positive earnings over several quarters, steady sales growth, a careful eye on expenses, and ideally some sort of reoccurring revenue (e.g. Edward's idea of ongoing license fees) to be a viable company commanding a decent valuation.

FYI, the medical industry in the US is an exceedingly tough nut to crack, very tightly controlled by big names (Siemens, GE, etc.) And very long sales cycles. I know becaues I almost started a medical software company with a friend who eventually did start that company (he had once been the medical marketing manager for Sun Microsystems).
icon url

Jimmy Quick

10/08/07 11:03 PM

#264 RE: xxplatinum #261

As for US sales, Edward just announced this at the beginning of July. The last email Edward had sent was on 8/24. I don't know what you expect to take place in that time, but I could easily see that no sales would have taken place in that period of time. I think we should give it some time and see if he has any news on US sales in his next shareholder update.